Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation

Reactivation of cytomegalovirus (CMV) or Epstein-Barr virus (EBV) is common after hematopoietic stem cell transplantation (HSCT). Previous researches have demonstrated that either CMV or EBV reactivation is associated with poor outcomes of HSCT. However, few studies investigate the impact of CMV and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jing-Rui, Shi, Da-Yu, Wei, Rong, Wang, Yu, Yan, Chen-Hua, Zhang, Xiao-Hui, Xu, Lan-Ping, Liu, Kai-Yan, Huang, Xiao-Jun, Sun, Yu-Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921792/
https://www.ncbi.nlm.nih.gov/pubmed/33664733
http://dx.doi.org/10.3389/fimmu.2020.620891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921792/
https://www.ncbi.nlm.nih.gov/pubmed/33664733
http://dx.doi.org/10.3389/fimmu.2020.620891

Ejemplares similares